Peer Comparison
Company | Market Price | MCAP(Cr) | P/B | P/E | EPS | ROE |
---|---|---|---|---|---|---|
AJANTPHARM | 1414.35(5.5%) | 16,524 | 5.6 | 29.6 | 27.4 | 19.3 |
JBCHEPHARM | 2119.85(0.0%) | 16,361 | 6.7 | 42.1 | 25.5 | 19.9 |
GLENMARK | 631.5(2.2%) | 17,178 | 1.0 | 14.2 | 14.2 | 12.3 |
SANOFI | 7136.9(4.4%) | 15,765 | 11.2 | 27.5 | 59.8 | 40.8 |
PFIZER | 3955.6(-0.1%) | 17,437 | 5.4 | 27.9 | 54.2 | 38.7 |
GLAND | 942(0.7%) | 15,353 | 1.9 | 19.8 | 24.8 | 18.6 |
IPCALAB | 748.05(3.1%) | 17,825 | 3.0 | 35.2 | 20.4 | 17.9 |
LAURUSLABS | 342.05(0.1%) | 18,333 | 4.5 | 24.1 | 26.0 | 28.1 |
PEL | 787.6(-0.8%) | 18,658 | 0.8 | 1.3 | 7.7 | 3.9 |
SUVENPHAR | 475.1(0.2%) | 12,071 | 6.9 | 27.9 | 44.5 | 37.8 |
NATCOPHARM | 621.7(-1.4%) | 11,155 | 2.5 | 17.5 | 17.5 | 14.4 |
APLLTD | 552.8(-0.2%) | 10,773 | 2.4 | 31.1 | 28.9 | 23.3 |
GLAXO | 1388.8(-0.4%) | 22,486 | 12.8 | 37.2 | 37.7 | 18.4 |
MEDPLUS | 813.2(1.2%) | 9,601 | 8.4 | 0.0 | 16.6 | 9.1 |
ASTRAZEN | 3487.4(1.0%) | 8,749 | 14.9 | 88.1 | 31.2 | 22.8 |